Kim Huynh-Ba

Kim Huynh-Ba has 28 years of experience in the quality management system, project management, strategic drug development, and stability sciences. She currently is the Executive Director of Pharmalytik (, providing consulting services to pharmaceutical companies. Kim is an Adjunct Professor at Temple University-School of Pharmacy, Widener University and Illinois Institute of Technology (IIT) teaching Quality Audit, Good Manufacturing Practices, ICH regulations, and Pharmaceutical Analysis. She is on the Editorial Board of the AAPS Open Journal and the Governing Board of Eastern Analytical Symposium.

Kim has been a United States Pharmacopeia volunteer for over a decade. She is currently a member of the USP Council of Experts, chairing the Chemical Medicines 4 Expert Committee (2015-2020). She also served as the Chair of the USP Good Documentation Practices Expert Panel (2010-2015), a member of the USP Impurities of Drug Products Expert Panel (2012-present), and a member of the USP Supplier Qualification Expert Panel (2019-present). 

Kim has been an ACS member for over 25 years. She is currently an Alternate Councilor of the ACS Delaware Section. She has been an ACS instructor for over 10 years, teaching several education courses for ACS National.

In addition to USP and ACS, she is also volunteered for PQRI, AAPS, EAS, PittCon, CHPA supporting different focus groups in those organizations.

Kim has authored numerous technical publications and book chapters and has spoken extensively, both domestic and internationally, of the compliance and quality areas. She is the editor of the “Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices” (2008) and “Pharmaceutical Stability Testing to Support Global Markets (2010).  She is working on a new manuscript entitled “Analytical chemistry: A handbook of Pharmaceutical GMP Laboratories”. She has published over 24 publications and appeared over 100 presentations domestic and internationally.